IPP Bureau
Surgeons at Aster RV Hospitals achieve milestone with removal of 345 gallstones
By IPP Bureau - November 28, 2023
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep
By IPP Bureau - November 28, 2023
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
Laurus Labs acquires 87.59% stake in Laurus Bio Private
By IPP Bureau - November 25, 2023
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
DxVx plans to make a license-in agreement of OVM-200
By IPP Bureau - November 25, 2023
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Lupin receives tentative approval from USFDA for Canagliflozin Tablets
By IPP Bureau - November 24, 2023
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor
Lupin receives approval from USFDA for Bromfenac Ophthalmic Solution
By IPP Bureau - November 24, 2023
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
AstraZeneca Pharma India receives permission to Import formulations of new drug for sale
By IPP Bureau - November 23, 2023
The receipt of this permission paves way for the launch of Olaparib film coated tablets in India
Merck to acquire Caraway Therapeutics
By IPP Bureau - November 23, 2023
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Fosun Pharma USA and Treehill Partners to invest in biopharma space
By IPP Bureau - November 23, 2023
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Lupin launches Vilfuro-G for COPD Management in India
By IPP Bureau - November 23, 2023
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Prevest Denpro launches range of innovative oral hygiene products ‘Oradox’
By IPP Bureau - November 23, 2023
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
Strides receives USFDA approval for generic Suprep bowel prep kit
By IPP Bureau - November 23, 2023
The Product will be manufactured at the company's facility in Bengaluru
Evive Biotech and Acrotech Biopharma receive FDA approval of Ryzneuta
By IPP Bureau - November 23, 2023
Lupin receives tentative approval from USFDA for Dapagliflozin Tablets
By IPP Bureau - November 22, 2023
Dapagliflozin Tablets (RLD Farxiga) had estimated annual sales of USD 7282 million in the US
Lupin receives approval from USFDA for Pitavastatin Tablets
By IPP Bureau - November 22, 2023
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
